Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
editorial
. 1997 Nov;43:1898-900, 1905-7.

Determining an ethical stance. Pharmaceutical industry involvement and family medicine residency training.

G Guyatt
PMCID: PMC2255179  PMID: 9386871

Full text

PDF
1898

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berings D., Blondeel L., Habraken H. The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice. Eur J Clin Pharmacol. 1994;46(6):501–505. doi: 10.1007/BF00196105. [DOI] [PubMed] [Google Scholar]
  2. Berings D., Blondeel L., Habraken H. The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice. Eur J Clin Pharmacol. 1994;46(6):501–505. doi: 10.1007/BF00196105. [DOI] [PubMed] [Google Scholar]
  3. Brotzman G. L., Mark D. H. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993 Mar;8(3):130–134. doi: 10.1007/BF02599757. [DOI] [PubMed] [Google Scholar]
  4. Brotzman G. L., Mark D. H. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993 Mar;8(3):130–134. doi: 10.1007/BF02599757. [DOI] [PubMed] [Google Scholar]
  5. Caudill T. S., Johnson M. S., Rich E. C., McKinney W. P. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996 Apr;5(4):201–206. doi: 10.1001/archfami.5.4.201. [DOI] [PubMed] [Google Scholar]
  6. Caudill T. S., Johnson M. S., Rich E. C., McKinney W. P. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996 Apr;5(4):201–206. doi: 10.1001/archfami.5.4.201. [DOI] [PubMed] [Google Scholar]
  7. Chren M. M., Landefeld C. S. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994 Mar 2;271(9):684–689. [PubMed] [Google Scholar]
  8. Chren M. M., Landefeld C. S. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA. 1994 Mar 2;271(9):684–689. [PubMed] [Google Scholar]
  9. Lexchin J. Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians. Can Fam Physician. 1994 Dec;40:2082–2087. [PMC free article] [PubMed] [Google Scholar]
  10. Lexchin J. Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians. Can Fam Physician. 1994 Dec;40:2082–2087. [PMC free article] [PubMed] [Google Scholar]
  11. Lexchin J., Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ. 1994 Jul 1;151(1):47–54. [PMC free article] [PubMed] [Google Scholar]
  12. Lexchin J., Holbrook A. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. CMAJ. 1994 Jul 1;151(1):47–54. [PMC free article] [PubMed] [Google Scholar]
  13. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993 Nov 15;149(10):1401–1407. [PMC free article] [PubMed] [Google Scholar]
  14. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993 Nov 15;149(10):1401–1407. [PMC free article] [PubMed] [Google Scholar]
  15. Waud D. R. Pharmaceutical promotions--a free lunch? N Engl J Med. 1992 Jul 30;327(5):351–353. doi: 10.1056/NEJM199207303270511. [DOI] [PubMed] [Google Scholar]
  16. Waud D. R. Pharmaceutical promotions--a free lunch? N Engl J Med. 1992 Jul 30;327(5):351–353. doi: 10.1056/NEJM199207303270511. [DOI] [PubMed] [Google Scholar]
  17. Wilkes M. S., Doblin B. H., Shapiro M. F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992 Jun 1;116(11):912–919. doi: 10.7326/0003-4819-116-11-912. [DOI] [PubMed] [Google Scholar]
  18. Wilkes M. S., Doblin B. H., Shapiro M. F. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992 Jun 1;116(11):912–919. doi: 10.7326/0003-4819-116-11-912. [DOI] [PubMed] [Google Scholar]
  19. Woollard R. F. Addressing the pharmaceutical industry's influence on professional behaviour. CMAJ. 1993 Aug 15;149(4):403–404. [PMC free article] [PubMed] [Google Scholar]
  20. Ziegler M. G., Lew P., Singer B. C. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995 Apr 26;273(16):1296–1298. [PubMed] [Google Scholar]
  21. Ziegler M. G., Lew P., Singer B. C. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995 Apr 26;273(16):1296–1298. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES